Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

NCT00648102 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Pancreatic Cancer
Bladder Cancer
Ovarian Cancer

Interventions

BIOLOGICAL: CDX-1307

Sponsor

Celldex Therapeutics